Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives

被引:16
|
作者
Deb, Pran Kishore [1 ]
Chandrasekaran, Balakumar [1 ]
Mailavaram, Raghuprasad [2 ]
Tekade, Rakesh Kumar [3 ]
Jaber, Abdul Muttaleb Yousef [1 ]
机构
[1] Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
[2] Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, India
[3] NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, India
关键词
PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; BINDING MODES; XANTHINE DERIVATIVES; DYNAMICS SIMULATIONS; MEDICINAL CHEMISTRY; AFFINITY; POTENT; QSAR;
D O I
10.1016/j.drudis.2019.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine receptors (ARs) are classified as A(1), A(2A),A(2B), and A(3) subtypes belonging to the superfamily of G-protein-coupled receptors (GPCRs). Several molecular modeling approaches have been developed for A(2B)AR and its antagonists, from the construction of a homology model, molecular docking, molecular dynamics (MD) simulations, and 3D quantitative structure-activity relationship (QSAR) modeling to pharmacophore modeling, each of which has different objectives and outcomes. In this review, we provide a systematic outline of advances in molecular modeling approaches towards A(2B)AR for deducing its structure and interactions with various types of antagonist. The information, methods and perspectives presented here provides impetus for medicinal chemists to discover potential ligands that can bind selectively with higher affinity to A(2B)AR.
引用
收藏
页码:1854 / 1864
页数:11
相关论文
共 50 条
  • [1] Discovery of new antagonists of the adenosine A2B receptor.
    Webb, TR
    Lvovskiy, D
    Melman, N
    Ji, X
    Linden, J
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U6 - U6
  • [2] Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives
    Chandrasekaran, Balakumar
    Samarneh, Sara
    Jaber, Abdul Muttaleb Yousef
    Kassab, Ghadir
    Agrawal, Nikhil
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (25) : 2741 - 2771
  • [3] Molecular Modeling and molecular dynamics simulation of the human A2B adenosine receptor.: The study of the possible binding modes of the A2B receptor antagonists
    Ivanov, AA
    Baskin, II
    Palyulin, VA
    Piccagli, L
    Baraldi, PG
    Zefirov, NS
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) : 6813 - 6820
  • [4] Prodrugs of A2B adenosine receptor antagonists
    Kalla, Rao
    Elzein, Elfatih
    Koltun, Dmitry
    Li, Xiaofen
    Perry, Thao
    Parkhill, Eric
    Zeng, Dewan
    Fong, Irving
    Leung, Kwan
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2008, 4 : S21 - S22
  • [5] Irreversible Antagonists for the Adenosine A2B Receptor
    Temirak, Ahmed
    Schlegel, Jonathan G.
    Voss, Jan H.
    Vaassen, Victoria J.
    Vielmuth, Christin
    Claff, Tobias
    Mueller, Christa E.
    MOLECULES, 2022, 27 (12):
  • [6] Discovery of novel quinolinone adenosine A2B antagonists
    McGuinness, Brian F.
    Ho, Koc-Kan
    Stauffer, Tara M.
    Rokosz, Laura L.
    Mannava, Neelima
    Kultgen, Steven G.
    Saionz, Kurt
    Klon, Anthony
    Chen, Weiqing
    Desai, Hema
    Rogers, W. Lynn
    Webb, Maria
    Yin, Juxing
    Jiang, Yan
    Li, Tailong
    Yan, Hao
    Jing, Konghua
    Zhang, Shengting
    Majumdar, Kanak Kanti
    Srivastava, Vikash
    Saha, Samiran
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7414 - 7420
  • [7] Molecular modeling studies on A2B adenosine receptor ligands
    Dal Ben, Diego
    PURINERGIC SIGNALLING, 2014, 10 (04) : 691 - 691
  • [8] Clinical targets of A2B adenosine receptor antagonists
    Linden, J
    Figler, RA
    Jacobson, KA
    Wang, GQ
    LaNoue, KF
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 556 - 556
  • [9] Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor
    Bedford, Simon T.
    Benwell, Karen R.
    Brooks, Teresa
    Chen, Ijen
    Comer, Mike
    Dugdale, Sarah
    Haymes, Tim
    Jordan, Allan M.
    Kennett, Guy A.
    Knight, Anthony R.
    Klenke, Burkhard
    LeStrat, Loic
    Merrett, Angela
    Misra, Anil
    Lightowler, Sean
    Padfield, Anthony
    Poullennec, Karine
    Reece, Mark
    Simmonite, Heather
    Wong, Melanie
    Yule, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5945 - 5949
  • [10] A2B adenosine receptor antagonists and their potential indications
    Zablocki, Jeff
    Elzein, Elfatih
    Kalla, Rao
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) : 1347 - 1357